Active Biotech confirms ANYARA tumor PET localization in cancer patients
04-Oct-2005 -
In an ongoing clinical Phase I study, specific tumor localization of Active Biotech's candidate drug ANYARA, has now been objectively confirmed. Using Positron Emission Tomography (PET) and radioactively labeled ANYARA, drug concentrations in tumor and normal tissues of individual patients have ...
Norway
positron emission tomography
tumors